# LNP solution Inc.

> Reevol Source machine-readable supplier card. Profile URL: https://source.reevol.com/zh-Hant/suppliers/lnp-solution/. Locale: zh-Hant.

## Profile status
- Unclaimed profile. The details below come from public business registries, trade-fair exhibitor lists and certification bodies, and have not yet been confirmed by the company itself. Fields that are absent here are unconfirmed, not negative findings.
- The company can claim this profile free at https://source.reevol.com/zh-Hant/claim/lnp-solution/ to confirm and complete it.

## Identity
- Legal name (en): LNP solution Inc.
- Business type: unknown
- Location: Hongcheon-gun, South Korea
- Year founded: 2022
- Employee range: 3

## Industry
- Primary: Pharmaceuticals
- Sub-industries: in silico services, molecular modeling, AI drug discovery, pharmaceutical development services, targeted compounds
- HS codes: 3004, 3002

## Digital footprint
- Website: http://www.lnpsolution.com/en/
- LinkedIn: http://www.linkedin.com/company/lnpsolution

## Summary
What we know: 成立於2022年，總部位於南韓洪川郡（已透過創立年份和位置數據驗證）。 3人團隊專注於藥物開發服務，包括AI藥物發現和分子建模（已透過團隊規模和產業標籤驗證）。 進口或交易HS編碼3004和3002項下的藥物產品（已透過HS編碼驗證）。

What the data suggests: 鑑於在矽基和AI驅動藥物發現方面的狹隘專注，可能是早期生物科技或藥物服務公司（由產業標籤和近期成立所示）。 根據對計算服務的重視，可能以合約研究或開發夥伴身份運營而非製造商（由產業標籤和藥物材料的HS編碼所示）。

Not yet verified: 網站, 認證, 貿易展覽會, 出口市場, 生產能力.

在聯絡前驗證LNP Solution Inc. - Reevol Source將在24小時內回傳驗證報告。

## Provenance
- Last enriched: 2026-10-21T15:49:15.039Z
- AI content last generated: 2026-10-21T17:17:36.808Z
- Source: Reevol Source (https://source.reevol.com). Underlying data from Reevol, sourced from public business registries, trade-fair exhibitor lists, certification bodies, and digital footprint.
- License: see https://source.reevol.com/zh-Hant/methodology/
